| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutics | Chief Financial Officer | Class A ordinary shares, par value $0.0001 per share | 628K | $5.7M | $9.09 | 08 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 08 Oct 2025 | 1 | $98.8K | 4 | 09 Oct 2025 | Chief Financial Officer |
| MLTX | MoonLake Immunotherapeutics | 27 Feb 2025 | 1 | $0 | 4 | 03 Mar 2025 | Chief Financial Officer |
| MLTX | MoonLake Immunotherapeutics | 19 Dec 2023 | 2 | -$5.92M | 4 | 21 Dec 2023 | Chief Financial Officer |
| MLTX | MoonLake Immunotherapeutics | 01 Oct 2023 | 3 | $0 | 4 | 03 Oct 2023 | Chief Financial Officer |
| MLTX | MoonLake Immunotherapeutics | 05 Apr 2023 | 6 | $0 | 4 | 07 Apr 2023 | Chief Financial Officer |
| MLTX | MoonLake Immunotherapeutics | 05 Apr 2022 | 0 | $0 | 3 | 15 Apr 2022 | Chief Financial Officer |